Calcium Acetate Capsule
NDC Package 69367-411-02

11-digit billing NDC: 69367041102 · Billing unit: EA · 200 EA per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Calcium Acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). This formulation utilizes a capsule delivery system. Marketed by Westminster Pharmaceuticals, Llc, this product is identified by NDC 69367-411 and is authorized under FDA application ANDA203179.

Identification & Billing

NDC Package Code
69367-411-02
Package Description
200 CAPSULE in 1 BOTTLE
Product Code
69367-411
11-Digit Billing Format
69367041102
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
200 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Calcium Acetate
Non-Proprietary Name
Calcium Acetate
Substance Name
Calcium Acetate
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CALCIUM ACETATE 667 mg/1
Pharmacologic Class
Usage Information
Calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).

Regulatory & Marketing

Labeler Name
Westminster Pharmaceuticals, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA203179
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-13-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69367-411-02 identifies a specific commercial package of 200 capsule in 1 bottle of Calcium Acetate, a human prescription drug labeled by Westminster Pharmaceuticals, Llc. This capsule is formulated for oral use and contains calcium acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Westminster Pharmaceuticals, Llc on June 13, 2025. The current certification is valid through December 31, 2027.

How is this Westminster Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69367041102. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 200 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69367-411-02
11-Digit CMS (5-4-2)
69367-0411-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.